Princeton Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,000	Closed	-$118K	–	269
2018 Q2	$118K	Hold	2,000	–	–	0.05%	124
2018 Q1	$91K	Buy	+2,000	New	+$91K	0.04%	134